Suchergebnisse - "Amiri, Mohammad Mehdi"

PubPharm (16)

1

Clinico-Pathological and Prognostic Significance of a Combination of Tumor Biomarkers in Iranian Patients With Breast Cancer

enthalten in: Clinical breast cancer | 2024

von Hassanzadeh Makoui, M. | Mobini, M. | Fekri, S. | +11

2

Potent anti-tumor immune response and tumor growth inhibition induced by HER2 subdomain fusion protein in a mouse tumor model

enthalten in: Journal of cancer research and clinical oncology | 2023

von Ghaedi, M. | Golsaz-Shirazi, F. | Bahadori, T. | +5

3

A Novel Fc-Engineered Anti-HER2 Bispecific Antibody With Enhanced Antitumor Activity

enthalten in: Journal of immunotherapy (Hagerstown, Md. : 1997) | 2023

von Mohammadi, M. | Jeddi-Tehrani, M. | Golsaz-Shirazi, F. | +10

4

Differential tumor inhibitory effects induced by HER3 extracellular subdomain-specific mouse monoclonal antibodies

enthalten in: Cancer chemotherapy and pharmacology | 2022

von Hassani, D. | Jeddi-Tehrani, M. | Yousefi, P. | +6

5

Potent synergistic anti-tumor activity of a novel humanized anti-HER2 antibody hersintuzumab in combination with trastuzumab in xenograft models

enthalten in: Investigational new drugs | 2021

von Shiravi, F. | Mohammadi, M. | Golsaz-Shirazi, F. | +9

6

A novel tumor inhibitory hybridoma monoclonal antibody with dual specificity for HER3 and HER2

enthalten in: Current research in translational medicine | 2021

von Hassani, D. | Amiri, M. | Mohammadi, M. | +6

7

Inhibitory Effect of Polyclonal Antibodies Against HER3 Extracellular Subdomains on Breast Cancer Cell Lines

enthalten in: Asian Pacific journal of cancer prevention : APJCP | 2020

von Mansouri-Fard, S. | Ghaedi, M. | Shokri, M. | +6

8

A Novel Anti-HER2 Bispecific Antibody With Potent Tumor Inhibitory Effects In Vitro and In Vivo

enthalten in: Frontiers in immunology | 2020

von Mohammadi, M. | Jeddi-Tehrani, M. | Golsaz-Shirazi, F. | +9

9

Development of a Novel Inhibitory Chimeric Anti-HER2 Monoclonal Antibody

enthalten in: Iranian journal of immunology : IJI | 2019

von Amiri, M. | Bahadori, T. | Soltantoyeh, T. | +4

10

Differential Effects of Inhibitory and Stimulatory Anti-HER2 Monoclonal Antibodies on AKT/ERK Signaling Pathways

enthalten in: Asian Pacific journal of cancer prevention : APJCP | 2018

von Soltantoyeh, T. | Bahadori, T. | Hosseini-Ghatar, R. | +7